Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF81 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | CTD-2192J16.20 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | PRB2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | DMGDH | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | B3GNTL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | BTF3L4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | KCNT1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | ZNF410 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | PDE6B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |